scholarly journals Integrate Partial Hydrolyzed Guar Gum in Postoperative Ileostomy Nutritional Management

2020 ◽  
Vol 4 (2) ◽  
pp. e000206
Author(s):  
Chiou Yi Ho ◽  
Atiki Falparado Ahmad ◽  
Sze Sian Woo ◽  
Tharmasilen Selvarajoo ◽  
Norshariza Jamhuri ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Guar Gum ◽  
Normal Diet ◽  
Nutritional Management ◽  
Acute Renal Injury ◽  
Diabetic Mellitus ◽  
Case Presentation ◽  
Conventional Ileostomy ◽  
Colorectal Cancer Patients ◽  
Positive Effect

Objective: This case report aimed to share our clinical practice about the Partially Hydrolysed Guar Gum (PHGG) incorporation in conventional ileostomy management. Case presentation: Patients A and B, who diagnosed with Diabetic Mellitus and Hypertension recto-sigmoid adenocarcinoma stage III, had high stoma output after anterior resection with covering ileostomy (more than 1200ml per day). PHGG was integrated into nutritional management and showed a positive effect in normalizing volume and the consistency of ileostomy stoma output. Discussion: Postoperative ileostomy patients often faced a higher risk for malnutrition among cancer patients. Persistent high stoma output without proper management could cause dehydration, depletion of magnesium and sodium, acute renal injury and malnutrition. High protein and high calories normal diet would normally be prescribed to postoperative colorectal cancer patients with an ileostomy. The addition of PHGG showed a positive effect in improving ileostomy consistency and output. Conclusion: The PHGG incorporation in the post-operative nutritional management for ileostomy revealed positive outcomes in consistency and volume of stoma output and nutritional intake.

scholarly journals Study protocol for an open labelled randomised controlled trial of perioperative oral nutrition supplement in breast and colorectal cancer patients undergoing elective surgery

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
T. X. Wong ◽  
S. T. Chen ◽  
S. H. Ong ◽  
S. Shyam ◽  
P. Kandasami ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Randomised Controlled Trial ◽  
Cancer Patients ◽  
Elective Surgery ◽  
Controlled Trial ◽  
Normal Diet ◽  
Oral Nutrition ◽  
Nutrition Supplement ◽  
Randomised Controlled ◽  
Colorectal Cancer Patients

Abstract Background While it is well established that perioperative use of oral nutrition supplement (ONS) improves nutrition status among severely malnourished surgical cancer patients, the evidence requires further substantiation for non-severely malnourished patients with cancer. This protocol paper presents the rationale and design of a randomised controlled trial to evaluate the effectiveness of preoperative as well as an extended 90-day postoperative use of ONS on nutritional and clinical outcomes among patients undergoing elective surgery for breast and colorectal cancer. Methods Patients with primary breast and colorectal cancer undergoing elective surgery are recruited from two tertiary hospitals. Eligible patients are assigned into one of the three intervention arms: (i) Group SS will receive ONS in addition to their normal diet up to 14 days preoperatively and postoperatively up to discharge; (ii) Group SS-E will receive ONS in addition to their normal diet up to 14 days preoperatively, postoperatively up to discharge and for an extended 90 days after discharge; and (iii) Group DS will receive ONS in addition to their normal diet postoperatively up to discharge from the hospital. The ONS is a standard formula fortified with lactium to aid in sleep for recovery. The primary endpoints include changes in weight, body mass index (BMI), serum albumin and prealbumin levels, while secondary endpoints are body composition (muscle and fat mass), muscle strength (handgrip strength), energy and protein intake, sleep quality, haemoglobin, inflammatory markers (transferrin, high sensitivity C-reactive protein, interleukin-6), stress marker (saliva cortisol), length of hospital stay and postoperative complication rate. Discussion This trial is expected to provide evidence on whether perioperative supplementation in breast and colorectal cancer patients presenting with high BMI and not severely malnourished but undergoing the stress of surgery would be beneficial in terms of nutritional and clinical outcomes. Trial registration ClinicalTrial.gov NCT04400552. Registered on 22 May 2020, retrospectively registered

Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study

2019 ◽  
Vol 29 (4) ◽  
pp. 289-293 ◽  
Author(s):  
Audrius Dulskas ◽  
Ausvydas Patasius ◽  
Donata Linkeviciute-Ulinskiene ◽  
Lina Zabuliene ◽  
Vincas Urbonas ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Type 2 Diabetes ◽  
Cohort Study ◽  
Cancer Patients ◽  
Metformin Treatment ◽  
National Cohort ◽  
Colorectal Cancer Patients ◽  
Positive Effect

scholarly journals Study Protocol of an Open Labelled Randomised Controlled Trial of Perioperative Oral Nutrition Supplement in Breast and Colorectal Cancer Patients Undergoing Elective Surgery

2021 ◽  
Author(s):  
Ting Xuan Wong ◽  
Seong Ting Chen ◽  
Shu Hwa Ong ◽  
Sangeetha Shyam ◽  
Kandasami Palayan ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Randomised Controlled Trial ◽  
Cancer Patients ◽  
Elective Surgery ◽  
Controlled Trial ◽  
Normal Diet ◽  
Oral Nutrition ◽  
Nutrition Supplement ◽  
Randomised Controlled ◽  
Colorectal Cancer Patients

Abstract Background: While it is well established that perioperative use of oral nutrition supplement (ONS) improves nutrition status among severely malnourished surgical cancer patients, the evidence requires further substantiation for non-severely malnourished patients with cancer. This protocol paper presents the rationale and design of a randomised controlled trial to evaluate the effectiveness of preoperative as well as an extended 3-month postoperative use of ONS on nutritional and clinical outcomes among patients undergoing elective surgery for breast and colorectal cancer. Methods: Patients with primary breast and colorectal cancer undergoing elective surgery are recruited from two tertiary hospitals. Eligible patients are assigned into one of the three intervention arms: i) Group SS will receive ONS in addition to their normal diet up to 14 days preoperatively and postoperatively up to discharge, ii) Group SS-E will receive ONS in addition to their normal diet up to 14 days preoperatively, postoperatively up to discharge and for an extended 3 months after discharge and iii) Group DS will receive ONS in addition to their normal diet postoperatively up to discharge from the hospital. The ONS is a standard formula fortified with lactium to aid in sleep for recovery. The primary endpoints include changes in weight, body mass index (BMI), serum albumin and prealbumin levels, while secondary endpoints are body composition (muscle and fat mass), muscle strength (handgrip strength), energy and protein intake, sleep quality, haemoglobin, inflammatory markers (transferrin, Hs-CRP, interleukin-6), stress marker (saliva cortisol), length of hospital stay and postoperative complication rate. Discussion: This trial is expected to provide evidence on whether perioperative supplementation in breast and colorectal cancer patients presenting with high BMI and not severely malnourished but undergoing the stress of surgery, would be beneficial in terms of nutritional, and clinical outcomes. Trial registration: ClinicalTrial.gov with the identifier: NCT04400552. Registered on 22 May 2020, retrospectively registered.

Associations of daily partner responses with fatigue interference and relationship satisfaction in colorectal cancer patients.

2018 ◽  
Vol 37 (11) ◽  
pp. 1015-1024
Author(s):  
Fabiola Müller ◽  
Marrit A. Tuinman ◽  
Ellen Stephenson ◽  
Ans Smink ◽  
Anita DeLongis ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Relationship Satisfaction ◽  
Cancer Patients ◽  
Colorectal Cancer Patients

Nutritional management in cancer patients with SARS-CoV-2infection

2020 ◽  
pp. 54-59
Author(s):  
E. V. Gameeva ◽  
A. V. Dmitriev ◽  
A. E. Shestopalov
Keyword(s):  
Cancer Patients ◽  
Nutritional Management

Safety and Quality of Life in the Treatment of Non-metastasic Colorectal Cancer Patients: 5-fluorouracil Versus Capecitabine

2019 ◽  
Author(s):  
Julia Sánchez-Gundín ◽  
Cristina Martín-Sabroso ◽  
Ana M. Fernández-Carballido ◽  
D. Barreda-Hernández ◽  
Ana I. Torres-Suárez
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Cancer Patients ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document